Annals of Surgical Oncology

, Volume 5, Issue 8, pp 667–669 | Cite as

Pancreatic cancer, gene delivery, and targets: The search for specificity

  • Harvey I. PassEmail author


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Roth J, Cristiano R. Gene therapy for cancer: what have we done and where are we going?J Natl Cancer Inst 1997;89:21.CrossRefPubMedGoogle Scholar
  2. 2.
    Bouvet M, Bold R, Lee J, et al. Adenovirus-mediated wild-type p53 tumor suppression gene therapy induces apoptosis and suppresses growth of human pancreatic cancer.Ann Surg Oncol 1998;5:681–8.PubMedGoogle Scholar
  3. 3.
    Block A, Chen S, Kosai K, Finegold M, Woo S. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors.Pancreas 1998;15:25–34.Google Scholar
  4. 4.
    Rosenfeld M, Vickers S, Raben D, et al. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.Ann Surg 1997;5:609–20.Google Scholar
  5. 5.
    Ohashi M, Kanai F, Tanaka T, et al. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.Jpn J Cancer Res 1998;89:457–62.PubMedGoogle Scholar
  6. 6.
    Aoki K, Yoshida T, Matsumoto N, et al. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene.Hum Gene Ther 1997;8:1105–13.PubMedGoogle Scholar
  7. 7.
    Aoki K, Yoshida T, Sugimura T, Terada M. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.Cancer Res 1998;55:3810–6.Google Scholar
  8. 8.
    Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.Cancer Res 1991;15:1744–8.Google Scholar
  9. 9.
    Clary B, Coveney E, Blazer D, Phillip R, Lyerly H. Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines.Surgery 1996;120:174–81.PubMedGoogle Scholar
  10. 10.
    Sato T, Yamauchi N, Sasaki H, et al. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor receptor gene transfection and mutein TNF administration.Cancer Res 1998;58:1677–83.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1998

Authors and Affiliations

  1. 1.Karmanos Cancer InstituteWayne State University, Harper HospitalDetroit

Personalised recommendations